BE898082A - Solution pour injection et procede pour sa preparation. - Google Patents

Solution pour injection et procede pour sa preparation. Download PDF

Info

Publication number
BE898082A
BE898082A BE0/211771A BE211771A BE898082A BE 898082 A BE898082 A BE 898082A BE 0/211771 A BE0/211771 A BE 0/211771A BE 211771 A BE211771 A BE 211771A BE 898082 A BE898082 A BE 898082A
Authority
BE
Belgium
Prior art keywords
injection
solution
antirheumatic
substances
preparation
Prior art date
Application number
BE0/211771A
Other languages
English (en)
French (fr)
Original Assignee
Gerot Pharmazeutika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerot Pharmazeutika filed Critical Gerot Pharmazeutika
Publication of BE898082A publication Critical patent/BE898082A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/211771A 1982-10-27 1983-10-26 Solution pour injection et procede pour sa preparation. BE898082A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT392982A AT376879B (de) 1982-10-27 1982-10-27 Verfahren zur herstellung einer injektionsloesung

Publications (1)

Publication Number Publication Date
BE898082A true BE898082A (fr) 1984-02-15

Family

ID=3557346

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/211771A BE898082A (fr) 1982-10-27 1983-10-26 Solution pour injection et procede pour sa preparation.

Country Status (7)

Country Link
AT (1) AT376879B (de)
BE (1) BE898082A (de)
CH (1) CH657525A5 (de)
DE (1) DE3337304A1 (de)
FR (1) FR2535205B1 (de)
LU (1) LU85040A1 (de)
NL (1) NL8303549A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
US5962536A (en) * 1998-07-31 1999-10-05 Komer; Gene Injectable propofol formulations
DE102007012644A1 (de) 2007-03-16 2008-09-18 Bayer Healthcare Ag Stabilisierung von Vitamin B12
AP3814A (en) * 2010-10-29 2016-09-30 Troikaa Pharmaceuticals Ltd Nasal compositions of vitamin b12

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1053736B (de) * 1956-03-02 1959-03-26 Konink Nl Gist & Spiritusfabri Verfahren zur Erhoehung der Loeslichkeit therapeutisch wirksamer Stoffe in Wasser
DE1249453B (de) * 1963-10-14
GB1076670A (en) * 1964-11-02 1967-07-19 Chugai Pharmaceutical Co Ltd A stabilised aqueous hydroxo cobalamin solution
DE2103387C3 (de) * 1971-01-26 1982-05-06 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Verwendung des Hydrochlorids von Glukosamin zur Herstellung von pharmazeutischen Präparaten
AU485607B2 (en) * 1972-12-04 1975-04-24 Ici Australia Limited Compositions
DE2522187C2 (de) * 1975-05-17 1977-10-28 Byk Gulden Lomberg Chem Fab Verwendung von Cystein oder dessen Säureadditionssalz und Natriumdisulfit zur Stabilisierung von injizierbaren, einen pH-Wert zwischen 7 und 9 aufweisenden, Vitamin B tief 12 und nichtsteroidal Entzündungshemmer enthaltenden Arzneimitteln
JPS54151668A (en) * 1978-05-22 1979-11-29 Teijin Ltd Production of fluffed fabric
LU80432A1 (de) * 1978-10-26 1979-03-19 Hoffmann K Verfahren zum herstellen einer injektionsloesung,die mono-phenylbutazon enthaelt,und injektionsloesung,hergestellt nach diesem verfahren
JPS5675436A (en) * 1979-11-22 1981-06-22 Eisai Co Ltd Solid pharmaceutical containing cobamamide or mecobalamin
JPS5675438A (en) * 1979-11-22 1981-06-22 Senjiyu Seiyaku Kk Method for stabilizing aqueous solution of cyanocobalamin
NZ195881A (en) * 1980-12-19 1984-08-24 W Lysaght Pharmaceutical compositions containing cobalt compounds

Also Published As

Publication number Publication date
DE3337304A1 (de) 1984-05-03
LU85040A1 (de) 1984-03-22
CH657525A5 (de) 1986-09-15
FR2535205A1 (fr) 1984-05-04
NL8303549A (nl) 1984-05-16
ATA392982A (de) 1984-06-15
FR2535205B1 (fr) 1987-02-06
AT376879B (de) 1985-01-10

Similar Documents

Publication Publication Date Title
DE69519667T2 (de) Verfahren zur stabilisierung von duocarmycinderivaten
JP2945718B2 (ja) 冷蔵庫温度で安定なホリニン酸塩水溶液並びにその製造方法
EP1895983A2 (de) Injizierbare zusammensetzungen und verfahren zur herstellung einer solchen zusammensetzung
DE3872029T2 (de) Rektal absorbierbare form von l-dopa.
US4482554A (en) Pharmaceutical compositions containing oxicam derivatives and process for their preparation
FR2853547A1 (fr) Compositions pharmaceutiques injectables contenant de la piperacilline et du tazobactame, et procede pour leur production
FR2547727A1 (fr) Compositions pharmaceutiques
JPH057371B2 (de)
JPH06263630A (ja) ビタミンａ類可溶化点眼剤
EP1285667A2 (de) Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
EA008908B1 (ru) Инъецируемый жидкий состав парацетамола
JP5297815B2 (ja) 医薬組成物
JP2021519817A (ja) 液体薬学的製剤
BE898082A (fr) Solution pour injection et procede pour sa preparation.
US4842856A (en) Parenteral solution
JP3242622B2 (ja) 非ステロイド系抗炎症薬の非経口で水混和性の非濃色注射可能組成物
CH670448A5 (de)
FR2772272A1 (fr) Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
US5886018A (en) Pharmaceutical composition for parenteral administration containing an indole-carboxylic acid
US3499088A (en) Stable aqueous solutions of coenzyme q with a polyoxyethylene hydrogenated castor oil and propylene glycol and process for the manufacture thereof
HU177873B (en) Further developped process for preparing an aequous solution containing a complex of n-/3-chloro-4-/4-chloro-phenoxy/-phenyl/-2-hydroxy-3,5-diiodo-benzamide with polyvinyl-pyrrolidone
BE1004051A4 (fr) Solution injectable et procede pour la preparer.
JP2001163776A (ja) 安定化された液剤
JPH0366617A (ja) 静脈内投与用フエニトインナトリウム製剤
JPS5821888B2 (ja) スイセイラフオキサニドセイザイ

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: GEROT-PHARMAZEUTIKA G.M.B.H.

Effective date: 19921031